Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)

NACompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

July 20, 2017

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Hepatitis CPeople Who Inject DrugsPWIDHCV Coinfection
Interventions
OTHER

Accessible Care

Accessible Care will be provided by co-locating a hepatitis treatment provider, together with a Hepatitis C Care Coordinator, on-site at our collaborating needle exchange program.

OTHER

Usual Care

Usual care entails referral to an on site HCV care coordinator (not provided by study)

Trial Locations (1)

10022

Lower East Side Harm Reduction Center, New York

All Listed Sponsors
collaborator

National Development and Research Institutes, Inc.

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Weill Medical College of Cornell University

OTHER

lead

City University of New York, School of Public Health

OTHER

NCT03214679 - Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID) | Biotech Hunter | Biotech Hunter